Hawaii Mesothelioma Researcher Makes Exciting New Discoveries
201207.11
Off
0

Hawaii Mesothelioma Researcher Makes Exciting New Discoveries

As an attorney who represents clients with mesothelioma, I have been privileged to visit the research laboratories at the University of Hawaii Cancer Center on several occasions.  I have met with the incredible staff and gifted researchers who are doing groundbreaking work to further our understanding of mesothelioma, an aggressive cancer caused by asbestos exposure….

201103.18
Off
0

Enhanced Quality of Life for Mesothelioma Patients a Priority at the IMP

The International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston has already made significant progress in developing new treatments to extend the lives of mesothelioma patients.  Under the leadership of Dr. David Sugarbaker, the specialists at the IMP have pioneered a number of innovative multimodality therapies.  IMP researchers have also collaborated with other…

200904.18
Off
0

Extreme Drug Resistance (EDR) – International Mesothelioma Program Develops Mesothelioma Treatment Aid

One of the most significant problems in the treatment of malignant mesothelioma is that the tumor can be resistant to many traditional forms of chemotherapy drugs.  This drug resistance varies from patient to patient.  Hence, weeks and even months of chemotherapy treatment could be wasted on a patient with malignant mesothelioma if that person’s tumor…

200903.18
Off
0

Cutting Edge Mesothelioma Clinical Trials at Memorial Sloan-Kettering

When faced with a life-threatening diagnosis of malignant mesothelioma, the patient and his or her loved ones will certainly seek the most advanced medical care to ensure the best possible outcome.  Memorial Sloan-Kettering Cancer Center is at the forefront of such cutting-edge medical research and care for mesothelioma patients.  Dr. Lee M. Krug, a thoracic…